Mimedx (MDXG) Preferred Stock Liabilities (2020 - 2023)

Mimedx has disclosed Preferred Stock Liabilities across 4 years of filings, most recently posting $92.5 million for Q3 2023.

• In Q3 2023, Preferred Stock Liabilities changed 0.0% year-over-year to $92.5 million; the TTM figure through Sep 2023 stood at $92.5 million (changed 0.0% YoY), while the FY2022 annual figure was $92.5 million, changed 0.0% from the prior year.
• Preferred Stock Liabilities came in at $92.5 million for Q3 2023 at Mimedx, roughly flat from $92.5 million in the prior quarter.
• In the past five years, Preferred Stock Liabilities ranged from a high of $92.5 million in Q2 2021 to a low of $91.1 million in Q3 2020.
• Average Preferred Stock Liabilities over 4 years is $92.3 million, with a median of $92.5 million recorded in 2021.
• Year-over-year, Preferred Stock Liabilities grew 1.52% in 2021 and changed 0.0% in 2022.
• Over 4 years, Preferred Stock Liabilities stood at $91.6 million in 2020, then rose by 1.01% to $92.5 million in 2021, then changed by 0.0% to $92.5 million in 2022, then changed by 0.0% to $92.5 million in 2023.
• Per Business Quant data, the three most recent Preferred Stock Liabilities figures were $92.5 million in Q3 2023, $92.5 million in Q2 2023, and $92.5 million in Q1 2023.